Cover Image
Market Research Report

Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2020

Published by GlobalData Product code 962513
Published Content info
Delivery time: 1-2 business days
Price
Back to Top
Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2020
Published: September 30, 2020 Content info:
Description

GlobalData's Medical Devices sector report, "Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Implantable Cardioverter Defibrillators (ICD) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart's rhythm and delivers electric pulses.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Implantable Cardioverter Defibrillators (ICD) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0996EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Implantable Cardioverter Defibrillators (ICD) Overview

3 Products under Development

  • 3.1 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
  • 3.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
  • 3.3 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
  • 3.4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
  • 3.5 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
  • 3.6 Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials

4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products under Development by Companies

  • 4.1 Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development
  • 4.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development

5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview

6 Implantable Cardioverter Defibrillators (ICD) - Recent Developments

7 Appendix

List of Tables

List of Tables

  • Table 1: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
  • Table 2: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
  • Table 3: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
  • Table 4: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
  • Table 5: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
  • Table 6: Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials
  • Table 7: Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development
  • Table 8: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
  • Table 9: Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Cardiac Rhythm Management Device - Product Status
  • Table 11: Cardiac Rhythm Management Device - Product Description
  • Table 12: AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Guardian - Product Status
  • Table 14: Guardian - Product Description
  • Table 15: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: EMBLEM MRI S-ICD System - Aged Patients - Product Status
  • Table 17: EMBLEM MRI S-ICD System - Aged Patients - Product Description
  • Table 18: S-ICD System 1.5 - Product Status
  • Table 19: S-ICD System 1.5 - Product Description
  • Table 20: S-ICD System 2.0 - Product Status
  • Table 21: S-ICD System 2.0 - Product Description
  • Table 22: VITALITY NXT Defibrillator - Product Status
  • Table 23: VITALITY NXT Defibrillator - Product Description
  • Table 24: Boston Scientific Corp - Ongoing Clinical Trials Overview
  • Table 25: EMBLEM MRI S-ICD System - Aged Patients - Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD)
  • Table 26: CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: MultiPulse Therapy Device - Product Status
  • Table 28: MultiPulse Therapy Device - Product Description
  • Table 29: CardiaLen, Inc. - Ongoing Clinical Trials Overview
  • Table 30: MultiPulse Therapy Device - A Clinical Feasibility Study to Evaluate the Safety and Performance of Low-energy Therapy in Patients with Atrial Fibrillation Energy Therapy in Patients with Atrial Fibrillation
  • Table 31: MultiPulse Therapy Device - An International Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Unpinning Termination Therapy in Patients with VT/VF
  • Table 32: Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Table-Top PaDe System - Product Status
  • Table 34: Table-Top PaDe System - Product Description
  • Table 35: InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: PICD - Product Status
  • Table 37: PICD - Product Description
  • Table 38: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Cardiac Sock Electrode And Implantable Defibrillator System - Product Status
  • Table 40: Cardiac Sock Electrode And Implantable Defibrillator System - Product Description

List of Figures

List of Figures

  • Figure 1: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
  • Figure 2: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
  • Figure 3: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
  • Figure 4: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
  • Figure 5: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
  • Figure 6: Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials
Back to Top